CN104411309A - 阿可拉定在制备用于治疗原发性肝癌的药物中的用途 - Google Patents

阿可拉定在制备用于治疗原发性肝癌的药物中的用途 Download PDF

Info

Publication number
CN104411309A
CN104411309A CN201380031578.7A CN201380031578A CN104411309A CN 104411309 A CN104411309 A CN 104411309A CN 201380031578 A CN201380031578 A CN 201380031578A CN 104411309 A CN104411309 A CN 104411309A
Authority
CN
China
Prior art keywords
liver
liver cancer
patient
hepatitis
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201380031578.7A
Other languages
English (en)
Other versions
CN104411309B (zh
Inventor
孟坤
李抒
丁红霞
郭玉明
徐妍
沈月秋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Shenogen Biomedical Co ltd
Original Assignee
Beijing Shenogen Biomedical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Shenogen Biomedical Co ltd filed Critical Beijing Shenogen Biomedical Co ltd
Publication of CN104411309A publication Critical patent/CN104411309A/zh
Application granted granted Critical
Publication of CN104411309B publication Critical patent/CN104411309B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

阿可拉定在制备治疗肝癌的药物中的用途，通过将由阿可拉定制备的药物针对性地用于治疗原发性肝癌，可以充分发挥该药物的肝癌治疗作用，使原发性肝癌患者能够得到及时有效的治疗，同时避免将该药物用于其他不适用的肝癌而延误治疗时机。对于防止盲目用药、实现合理用药有着重要意义。

Description

PCT国内申请，说明书已公开。

Claims (1)

  1. PCT国内申请，权利要求书已公开。
CN201380031578.7A 2013-04-24 2013-04-24 阿可拉定在制备用于治疗原发性肝癌的药物中的用途 Active CN104411309B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/074622 WO2014172857A1 (zh) 2013-04-24 2013-04-24 阿可拉定在制备用于治疗原发性肝癌的药物中的用途

Publications (2)

Publication Number Publication Date
CN104411309A true CN104411309A (zh) 2015-03-11
CN104411309B CN104411309B (zh) 2018-03-09

Family

ID=51790987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380031578.7A Active CN104411309B (zh) 2013-04-24 2013-04-24 阿可拉定在制备用于治疗原发性肝癌的药物中的用途

Country Status (3)

Country Link
CN (1) CN104411309B (zh)
HK (1) HK1207328A1 (zh)
WO (1) WO2014172857A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486196A (zh) * 2015-05-20 2018-09-04 佛山市金骏康健康科技有限公司 一种淫羊藿次苷i或淫羊藿次苷c的制备方法
CN111481640B (zh) * 2020-04-27 2022-04-05 江苏省中医药研究院 抗肝癌微乳纳米组合物及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101528038A (zh) * 2006-10-25 2009-09-09 盛诺基医药科技有限公司 用于治疗与雌激素受体相关的疾病的化合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101103973A (zh) * 2006-09-14 2008-01-16 殷正丰 一种抗肿瘤药物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101528038A (zh) * 2006-10-25 2009-09-09 盛诺基医药科技有限公司 用于治疗与雌激素受体相关的疾病的化合物和方法

Also Published As

Publication number Publication date
HK1207328A1 (zh) 2016-01-29
WO2014172857A1 (zh) 2014-10-30
CN104411309B (zh) 2018-03-09

Similar Documents

Publication Publication Date Title
Iino et al. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
CN110248646A (zh) 包含吡非尼酮的缓释组合物用于治疗和逆转人脂肪性肝炎(nafld/nash)的药物用途
Bai et al. Anti-hepatic fibrosis effects of a novel turtle shell decoction by inhibiting hepatic stellate cell proliferation and blocking TGF-β1/Smad signaling pathway in rats
CN105120876A (zh) 癌症的治疗
Zhang et al. Total flavone of Abelmoschus manihot ameliorates Crohn's disease by regulating the NF‑κB and MAPK signaling pathways
Li et al. Cidan inhibits liver cancer cell growth by reducing COX‑2 and VEGF expression and cell cycle arrest Corrigendum in/etm/10/4/1609
CN104411309B (zh) 阿可拉定在制备用于治疗原发性肝癌的药物中的用途
JP4556009B2 (ja) 抗炎症剤、アレルギー性疾患予防又は改善剤及び機能性食品
US20230057861A1 (en) Use of corydalis saxicola bunting and formulation thereof in preparation of drug for treating non-alcoholic fatty liver diseases
JP6433686B2 (ja) 癌治療用組成物の調製のためのイカリチンの使用
TWI797426B (zh) 西奧羅尼用於小細胞肺癌的治療
CN104983814A (zh) 一种白头翁提取物及其在制备防治肺纤维化药物中的应用
CN107260769A (zh) 一种治疗肿瘤、降糖祛痛风的中药
CN110917296A (zh) 一种中药组合物在制备用于糖尿病肾病药物中的应用
CN109106715B (zh) 8-羟基喹啉类药物或其盐在制备用于治疗与brd4相关的疾病的药物中的应用
CN105126030A (zh) 一种辅助抗肺癌的壮药组合物
Zhou et al. Xiao-Chai-Hu Tang in treating model mice with D-galactosamine-induced liver injury
CN109568302B (zh) 一种治疗晚期肝癌的药物复合物及其应用
CN105497167A (zh) 猫爪草在制备治疗和/或预防溃疡性结肠炎药物方面的新用途
EP3572082A1 (en) Uses of egfr/her2 inhibitor combined with pyrimidine-type anti-metabolic drug
CN110613822A (zh) 一种抗乙肝病毒中药配方
CN112641779B (zh) Gw441756在制备预防和/或治疗脂肪肝药物中的应用
CN109568430A (zh) 一种免疫增强剂的制备方法和应用
CN115813921B (zh) 化合物16f16及其衍生物在制备抗乙型肝炎病毒药物中的应用
CN116421590B (zh) 二乙酸氯己定在制备预防或/和治疗肝癌的药物中的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1207328

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1207328

Country of ref document: HK